Nectar Lifesciences Cash Flow Annual

Trade
BSE: 532649 | NSE: NECLIFE | ISIN: INE023H01027 | Sector: Biotechnology & Drugs
33.32 -0.68 (-2.00%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 18.27-42.4234.08-59.45
Depreciation/ Depletion 60.7259.1256.9760.25
Non- Cash Items 76.8339.0368.5064.83
Changesin Working Capital 68.8777.93-64.54-44.26
Cashfrom Operating Activities 224.69133.6595.0121.38
Capital Expenditures -29.42-30.06-24.97-31.24
Other Investing Cash Flow Items Total 12.3981.7641.612.62
Cashfrom Investing Activities -17.0351.7016.64-28.62
Financing Cash Flow Items -87.14-79.49-78.81-112.04
Issuance( Retirement)of Debt Net -118.29-106.10-39.54124.65
Cashfrom Financing Activities -205.43-185.58-119.3811.49
Net Changein Cash 2.23-0.23-7.734.25
Cash Interest Paid 87.1479.4978.81112.04
Cash Taxes Paid 0.000.000.003.71
Total Cash Dividends Paid ---1.03-1.12
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts